Novel Metrics of HER2 Heterogeneity in HER2-Positive and HER2-Low Breast Cancer via High Dimensional Multiplexed Immunofluorescence Spatial Profiling
SABCS 2023
Contact Us To Get Started!
Work with us – your premier oncology partner – to optimize cancer care for patients